NeuroMET mini symposium October 2018
05 Nov 2018
The third NeuroMET mini symposium was held at the Institute for Regenerative Medicine & Biotherapy, Montpellier, France, on October 24, 2018. It was attended by Consortium members and stakeholders from clinical laboratories, industry and academia.
Following a brief introduction to NeuroMET, the symposium included sessions on MRI, patient-centred outcome measures and biomarkers, and prompted much discussion between the participants.
Find more details of the presentations below.
Correlations Between Changes of Different MRI derived Biomarkers in Alzheimer's
Disease: An Update on Preliminary Results from the NeuroMET project
- Ariane Fillmer, Physikalisch-Technische Bundesanstalt, Berlin
Quality assured Patient-Centred Outcome Measures,
- Leslie Pendrill, RI:SE, Göteburg
An update on the development of a reference measurement procedure for
quantification of α-synuclein in CSF.
- Adam Cryar, LGC, Teddington
The NeuroMET contribution towards standardisation of total tau measurements
- Amandine Boeuf, LNE, Paris
Implementation of standard additions to determine endogenous analyte concentrations by immunoassays to overcome biological matrix interference
- Susan Pang, LGC, Teddington
Profiling of intact proteins in the CSF of Alzheimer's disease patients using top-down
clinical proteomics: revealing specific isoform biomarker candidates
- Christophe Hirtz, CHU Montpellier, Montpellier